Bio-Rad Laboratories-B
- Market cap
- 9.76B
- P/E (TTM)i
- 44.47
- P/Bi
- 1.36
- EPSi
- 27.85
- Div yieldi
- 0.00%
- 52W posi
- 100%
Anonymous reader poll. Unscientific, not investment advice.
Bio-Rad Laboratories-B shares were changing hands at 365.08, little changed on the day. Its market capitalisation is about 9.76B, the #1492 most valuable US-listed company we track. Over the past year the stock has ranged from 244.54 to 365.08; it now sits 100% up that band.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 2 weeks.
- Recent price momentum is +25.6% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 365.08
- Open
- 0.00
- Day range
- 0.00 - 0.00
- Avg price
- 377.01
- Volume
- 12
- Turnover
- 4.90K
- Turnover ratei
- 0.00%
- Volume ratioi
- 1.40
- Amplitudei
- 0.00%
- 52-week rangei
- 244.54 - 365.08
Valuation
- P/Ei
- 13.11
- P/E (TTM)i
- 44.47
- P/Bi
- 1.36
- EPSi
- 27.85
- Book value / shi
- 268.30
- Net profit
- 744.66M
- Net assets
- 7.17B
Share structure
- Market cap
- 9.76B
- Float capi
- 7.70B
- Shares out
- 26.74M
- Float sharesi
- 21.10M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
Trading activity
Net capital flow main funds, last 45 sessions
-308.60K net over the window
Short interest
- Shares short
- 2
- % of floati
- 0.00%
- Days to coveri
- 1.00
- As of
- 2026-08-14
Frequently asked questions
What is the current stock price of Bio-Rad Laboratories-B (BIO.B)?
Bio-Rad Laboratories-B last traded at 365.08. The quote on this page refreshes every few seconds while US markets are open.
What is Bio-Rad Laboratories-B's market cap?
About 9.76B.
What is the P/E ratio of Bio-Rad Laboratories-B?
The trailing twelve-month P/E is 44.47. The Valuation tab shows it against the stock's own five-year range.
Does Bio-Rad Laboratories-B pay a dividend?
Bio-Rad Laboratories-B does not currently pay a regular dividend.
What is Bio-Rad Laboratories-B's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Bio-Rad Laboratories-B a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.